George Gessner

1.1k total citations
41 papers, 916 citations indexed

About

George Gessner is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, George Gessner has authored 41 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Cancer Research and 10 papers in Organic Chemistry. Recurrent topics in George Gessner's work include Synthesis and Biological Activity (9 papers), Receptor Mechanisms and Signaling (9 papers) and Neuropeptides and Animal Physiology (6 papers). George Gessner is often cited by papers focused on Synthesis and Biological Activity (9 papers), Receptor Mechanisms and Signaling (9 papers) and Neuropeptides and Animal Physiology (6 papers). George Gessner collaborates with scholars based in United States, United Kingdom and Japan. George Gessner's co-authors include Robert G. Pendleton, John L. Sawyer, Thelma S. Angeles, Michael F. Jarvis, Stanley T. Crooke, Kathryn E. Flaim, Joseph Weinstock, Sheryl L. Meyer, Robert L. Hudkins and John T. Durkin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

George Gessner

40 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Gessner United States 17 506 222 173 126 104 41 916
Jutta Hegler Germany 9 742 1.5× 211 1.0× 153 0.9× 63 0.5× 129 1.2× 10 1.1k
Edurne Cenarruzabeitia Spain 18 369 0.7× 275 1.2× 180 1.0× 79 0.6× 29 0.3× 50 866
Simon Q.J. Rice United Kingdom 11 463 0.9× 225 1.0× 54 0.3× 63 0.5× 115 1.1× 14 901
Nenad Nešković France 23 785 1.6× 172 0.8× 108 0.6× 64 0.5× 38 0.4× 59 1.2k
Jiann-Wu Wei Canada 16 619 1.2× 248 1.1× 43 0.2× 132 1.0× 23 0.2× 45 848
William K. Sonnenburg United States 15 790 1.6× 87 0.4× 96 0.6× 403 3.2× 81 0.8× 16 1.1k
Fang‐Yu Lee Taiwan 13 374 0.7× 69 0.3× 225 1.3× 142 1.1× 98 0.9× 21 859
André Uzan France 19 371 0.7× 338 1.5× 68 0.4× 63 0.5× 18 0.2× 34 815
K.R. Hunter United Kingdom 11 189 0.4× 195 0.9× 77 0.4× 36 0.3× 26 0.3× 20 847
Kayoko Moroi Japan 14 556 1.1× 143 0.6× 23 0.1× 101 0.8× 61 0.6× 51 891

Countries citing papers authored by George Gessner

Since Specialization
Citations

This map shows the geographic impact of George Gessner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Gessner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Gessner more than expected).

Fields of papers citing papers by George Gessner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Gessner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Gessner. The network helps show where George Gessner may publish in the future.

Co-authorship network of co-authors of George Gessner

This figure shows the co-authorship network connecting the top 25 collaborators of George Gessner. A scholar is included among the top collaborators of George Gessner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Gessner. George Gessner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murakata, Chikara, Masami Kaneko, George Gessner, et al.. (2002). Mixed lineage kinase activity of indolocarbazole analogues. Bioorganic & Medicinal Chemistry Letters. 12(2). 147–150. 83 indexed citations
2.
Maroney, Anna C., James P. Finn, Thomas J. Connors, et al.. (2001). CEP-1347 (KT7515), a Semisynthetic Inhibitor of the Mixed Lineage Kinase Family. Journal of Biological Chemistry. 276(27). 25302–25308. 180 indexed citations
3.
Jarvis, Michael F., George Gessner, Linda Merkel, et al.. (1999). Differential effects of the adenosine A1 receptor allosteric enhancer PD 81,723 on agonist binding to brain and adipocyte membranes. Brain Research. 840(1-2). 75–83. 10 indexed citations
4.
Gessner, George, et al.. (1997). [125I]BQ3020, a novel endothelin agonist selective for the endothelinB receptor subtype. Brain Research Protocols. 1(1). 23–26. 3 indexed citations
5.
6.
Jarvis, Michael F., et al.. (1994). Pharmacological characterization of the rat cerebellar endothelinB (ETB) receptor using the novel agonist radioligand [125I]BQ3020. Brain Research. 665(1). 33–38. 5 indexed citations
7.
Jarvis, Michael F., George Gessner, Geneviève Martin, et al.. (1992). Characterization of [125I]acidic fibroblast growth factor binding to the cloned human fibroblast growth factor receptor, FGF-flg, on NIH 3T3 cell membranes: inhibitory effects of heparin, pertussis toxin and guanine nucleotides.. Journal of Pharmacology and Experimental Therapeutics. 263(1). 253–263. 2 indexed citations
8.
Pendleton, Robert G., et al.. (1990). Comparative effects of angiotensin II and angiotensin III in rabbit adrenal and aortic tissues.. Journal of Pharmacology and Experimental Therapeutics. 256(2). 614–620. 13 indexed citations
9.
Fitzpatrick, Leo R., Charles Pendley, G.E. Martin, et al.. (1990). RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.. Journal of Pharmacology and Experimental Therapeutics. 254(2). 450–455. 17 indexed citations
10.
Pendleton, Robert G., et al.. (1989). Studies on inhibition of angiotensin II receptors in rabbit adrenal and aorta.. Journal of Pharmacology and Experimental Therapeutics. 248(2). 637–643. 16 indexed citations
11.
Pendleton, Robert G., et al.. (1989). Studies defining minimal receptor domains for angiotensin II.. Journal of Pharmacology and Experimental Therapeutics. 250(1). 31–36. 10 indexed citations
12.
Flaim, Kathryn E., George Gessner, Stanley T. Crooke, Henry M. Sarau, & Joseph Weinstock. (1985). Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam1 (SKF 82526) to D-1 receptors in rat striatum. Life Sciences. 36(15). 1427–1436. 31 indexed citations
13.
Bondinell, William E., James S. Frazee, Gerald R. Girard, et al.. (1983). Inhibitors of Phenylethanolamine N-Methyltransferase and Epinephrine Biosynthesis: A Potential Source of New Drugs. Drug Metabolism Reviews. 14(4). 709–721. 15 indexed citations
14.
Pendleton, Robert G., et al.. (1979). Studies on SK&F 29661, an organ-specific inhibitor of phenylethanolamine N-methyltransferase.. PubMed. 208(1). 24–30. 31 indexed citations
15.
Pendleton, Robert G., et al.. (1977). The effects of an inhibitor of phenylethanolamine N-methyltransferase upon stimulated adrenal catecholamine release and excretion in the rat. Naunyn-Schmiedeberg s Archives of Pharmacology. 297(3). 245–250. 10 indexed citations
16.
Pendleton, Robert G., et al.. (1976). Studies on adrenal phenylethanolamine N- methyltransferase (PNMT) with S K & F 64139, a selective inhibitor.. PubMed. 197(3). 623–32. 58 indexed citations
17.
Pendleton, Robert G., et al.. (1976). Studies on adrenal phenylethanolamine N- methyltransferase (PNMT) with S K & F 64139, a selective inhibitor.. Journal of Pharmacology and Experimental Therapeutics. 197(3). 623–632. 3 indexed citations
18.
Pendleton, Robert G. & George Gessner. (1975). Evidence That Dopamine Is Not a Substrate for Adrenal Phenylethanolamine N-Methyltransferase. Molecular Pharmacology. 11(2). 232–235. 8 indexed citations
19.
Pendleton, Robert G., et al.. (1974). STUDIES ON SK&F 7698; AN INHIBITOR OF PHENYLETHANOLAMINE N-METHYLTRANSFERASE (PNMT). Journal of Pharmacology and Experimental Therapeutics. 190(3). 551–562. 1 indexed citations
20.
Pendleton, Robert G., et al.. (1974). Studies on SK and F 7698; an inhibitor of phenylethanolamine N-methyltransferase (PNMT).. PubMed. 190(3). 551–62. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jutta Hegler Breakdown of academic impact, for papers by Edurne Cenarruzabeitia Breakdown of academic impact, for papers by Simon Q.J. Rice Breakdown of academic impact, for papers by Nenad Nešković Breakdown of academic impact, for papers by Jiann-Wu Wei Breakdown of academic impact, for papers by William K. Sonnenburg Breakdown of academic impact, for papers by Fang‐Yu Lee Breakdown of academic impact, for papers by André Uzan Breakdown of academic impact, for papers by K.R. Hunter Breakdown of academic impact, for papers by Kayoko Moroi
Rankless by CCL
2026